Inspira Technologies Oxy B.H.N. Ltd.

General Information

We are a specialty medical device company engaged in the research, development, manufacture, and marketing of proprietary respiratory support technology that is intended to provide an alternative to invasive mechanical ventilation, or MV, which is the standard of care today for the treatment of respiratory failure. Although it may be lifesaving, MV is associated with increased costs of care, extended lengths of stay in the hospital, frequent incidence of infections, ventilator dependence and mortality. Using our state-of-the-art respiratory support technology, our goal is to set a new standard of care and to provide patients with acute respiratory distress syndrome an opportunity to maintain spontaneous breathing and avoid the various risks associated with the use of MV. As part of our strategy to reach this goal, and in parallel to pursuing regulatory approvals, we are actively working to establish collaborations with key opinion leaders and globally ranked hospitals, to provide endorsement and early clinical adoption of our respiratory support technology in order for us to achieve strong market penetration at market launch.

(Note: There were some indications that this micro-cap IPO might get priced during the week of April 5, 2021, but the deal did not get done.)

Employees: 89
Founded: 2018
Contact Information
Address 2 Ha-Tidhar St., Ra’anana, 4366504 Israel
Phone Number +972.4.6230333
Web Address
View Prospectus: Inspira Technologies Oxy B.H.N. Ltd.
Financial Information
Market Cap $78.5mil
Revenues $0 mil (last 12 months)
Net Income $-8.8 mil (last 12 months)
IPO Profile
Symbol IINN
Exchange NASDAQ
Shares (millions): 2.8
Price range $5.50 - $6.50
Est. $ Volume $16.5 mil
Manager / Joint Managers The Benchmark Company
CO-Managers National Securities Corporation
Expected To Trade:
Status: TBA
Quiet Period Expiration Date:
Lock-Up Period Expiration Date:
SCOOP Rating
Rating Change